.png?width=399&height=399&name=Deepak%20Behera%20(2026%20ep).png)
With more than two decades of experience spanning clinical practice, translational research, and global industry leadership, Bracken Senior Partner Dr. Deepak Behera has actively shaped how radiopharmaceuticals are developed, evaluated, and delivered to patients. As President and CEO of Adaptive Research and Senior Partner at Bracken, Deepak is an expert in connecting science, strategy, and real-world execution.
In this episode of Fractals: Life Science Conversations, Deepak and host Colin Miller discuss:
-
Why imaging is more than visualization, and how it functions as a powerful biomarker in theranostics
-
When diagnostics should stand on their own, rather than being treated as a secondary companion to therapy
-
How imaging-only studies can uncover unexpected biology and sharpen indication strategy early
-
The operational, economic, and educational realities that determine whether radiopharmaceuticals succeed post-approval
-
Why multidisciplinary skill sets—not linear career paths—are essential for the next generation of radiopharma leaders
Tune in to Fractals on your preferred podcast platform, and reach out to Bracken to learn how we help sponsors navigate imaging-driven development and radiopharmaceutical strategy with confidence.
Click here to read the transcript version of this episode.
